Analysis
This edition also looks at public market appetite for PE-backed healthcare companies.
1
Beyond the Buyout: China’s PE recovery may see selective LP re-entry
2
Robotics startup Hivebotics raises $6m, and other SE Asia deals
3
KKR to acquire minority stake in Malaysia's Avisena Healthcare
4
Morgan Stanley PE Asia explores Omega-ClearMedi merger in India
5
Accel-backed Rentomojo eyes $444m valuation in India IPO
More Stories
Indonesian fintech Amartha said to lead BroilerX restructuring
Creador’s food ingredient business draws a bevy of investors in potential sale
Blue Pool Capital, others said to have invested in DatViet’s IPO
Shell weighs potential $1b sale of Malaysian facility
Hesai founders’ Sharpa bags $670m, unveils fully automated robot restaurant
The so-called instant retail has emerged as the new battleground in online shopping.
IPOs & Markets
The developer of popular AI large language model Kimi is aiming to raise $3 billion.
Investors and entrepreneurs are paying thousands of dollars for rare access to Chinese factories.
It is targeting a valuation of about 28 billion yuan ($4.2 billion).
Deals
The company is looking beyond its core Greater China footprint to drive its next phase of growth.
Enflame is one of China’s leading AI chip startups.
Venture Capital
The funding was led by China-focused venture capital firm MPCi.
Susquehanna becomes the latest global trading firm to tap HK as a gateway to trade in Chinese markets.
Its stock tanked by as much as 10% on Tuesday.
